Credicorp slides as Peru’s tight presidential runoff count keeps investors on edge

Credicorp Ltd. (BAP) is down 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is Peru political-risk repricing after the June 7 presidential runoff, as vote-count uncertainty and a razor-thin margin between candidates pushed investors to reduce exposure to Peru-linked financials. A weaker local risk tone (including FX jitters) can spill into U.S.-listed ADRs like BAP even when there is no company-specific headline.

Details:

Peru’s presidential runoff remained extremely close as counting continued into Monday, leaving the policy outlook unclear in the near term.

Local-market nerves showed up in currency sentiment as the U.S. dollar strengthened versus the Peruvian sol in Monday trading, a common pattern when political uncertainty rises.

Credicorp’s core earnings base is closely tied to Peru through its main banking and financial-services subsidiaries, so changes in Peru risk premia can move the stock quickly.

Credicorp has flagged Peru’s electoral and political environment as a key macro risk factor in its public filings, which can become more market-relevant around election events.

Sources:

Reuters, Associated Press, Credicorp (Form 20-F), Anadolu Agency

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BAP Insider Trading Activity

$BAP insiders have traded $BAP stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $BAP stock by insiders over the last 6 months:

ALEJANDRO PEREZ-REYES (CFO) sold 1,073 shares for an estimated $362,137

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive BAP Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$BAP Hedge Fund Activity

We have seen 212 institutional investors add shares of $BAP stock to their portfolio, and 216 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL WORLD INVESTORS added 1,710,995 shares (+77.9%) to their portfolio in Q1 2026, for an estimated $580,335,284
BLACKROCK, INC. added 706,477 shares (+17.4%) to their portfolio in Q1 2026, for an estimated $239,622,868
ARGA INVESTMENT MANAGEMENT, LP removed 698,243 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $236,830,060
BANK OF NOVA SCOTIA removed 511,961 shares (-61.7%) from their portfolio in Q1 2026, for an estimated $173,646,931
DODGE & COX removed 460,765 shares (-11.9%) from their portfolio in Q1 2026, for an estimated $156,282,272
CAPITAL RESEARCH GLOBAL INVESTORS added 459,435 shares (+inf%) to their portfolio in Q1 2026, for an estimated $155,831,163
ACADIAN ASSET MANAGEMENT LLC added 334,363 shares (+104.0%) to their portfolio in Q1 2026, for an estimated $113,409,242

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$BAP Price Targets

Multiple analysts have issued price targets for $BAP recently. We have seen 4 analysts offer price targets for $BAP in the last 6 months, with a median target of $381.0.

Here are some recent targets:

Yuri Fernandes from JP Morgan set a target price of $415.0 on 05/28/2026
Thiago Batista from UBS set a target price of $412.0 on 05/26/2026
Carlos Gomez-Lopez from HSBC set a target price of $350.0 on 05/19/2026
Tito Labarta from Goldman Sachs set a target price of $330.0 on 02/17/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.